rs137854528
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PVS1PP5_ModerateBS2_Supporting
The NM_213599.3(ANO5):c.2311_2312delCA(p.Gln771fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,613,210 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
ANO5
NM_213599.3 frameshift
NM_213599.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.108
Genes affected
ANO5 (HGNC:27337): (anoctamin 5) This gene encodes a member of the anoctamin family of transmembrane proteins. The encoded protein is likely a calcium activated chloride channel. Mutations in this gene have been associated with gnathodiaphyseal dysplasia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 11-22274639-CCA-C is Pathogenic according to our data. Variant chr11-22274639-CCA-C is described in ClinVar as [Pathogenic]. Clinvar id is 39277.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-22274639-CCA-C is described in Lovd as [Pathogenic].
BS2
High AC in GnomAd4 at 7 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANO5 | NM_213599.3 | c.2311_2312delCA | p.Gln771fs | frameshift_variant | 20/22 | ENST00000324559.9 | NP_998764.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANO5 | ENST00000324559.9 | c.2311_2312delCA | p.Gln771fs | frameshift_variant | 20/22 | 1 | NM_213599.3 | ENSP00000315371.9 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151874Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
151874
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251176Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135754
GnomAD3 exomes
AF:
AC:
9
AN:
251176
Hom.:
AF XY:
AC XY:
5
AN XY:
135754
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461336Hom.: 0 AF XY: 0.0000220 AC XY: 16AN XY: 726972
GnomAD4 exome
AF:
AC:
31
AN:
1461336
Hom.:
AF XY:
AC XY:
16
AN XY:
726972
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151874Hom.: 0 Cov.: 32 AF XY: 0.0000809 AC XY: 6AN XY: 74170
GnomAD4 genome
AF:
AC:
7
AN:
151874
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74170
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2Other:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2L Pathogenic:1Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 20, 2012 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 39277). This premature translational stop signal has been observed in individual(s) with autosomal recessive limb-girdle muscular dystrophy (PMID: 22402862). This variant is present in population databases (rs746988059, gnomAD 0.03%). This sequence change creates a premature translational stop signal (p.Gln771Alafs*8) in the ANO5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANO5 are known to be pathogenic (PMID: 21186264, 23606453, 25891276, 30919934). - |
not provided Other:1
not provided, no classification provided | literature only | ANO5 @LOVD | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at